ÂÜÀòÂÒÂ×

Mr. Margolis serves as a member of the Board of Directors, Senior Vice President, Chief Financial Officer, Treasurer and Secretary of RespireRx Pharmaceuticals Inc., where he has been an executive officer and member of the Board of Directors since March 2013. RespireRx is Mr. Margolis’ primary professional responsibility. Mr. Margolis has served as President of Aurora Capital LLC, a boutique investment bank and securities firm specializing in the life science sector, since he founded its predecessor company, Aurora Capital Corp. in 1994. Aurora Capital LLC was SEC registered and a FINRA member firm until voluntarily withdrawing effective July 2021 and has been inactive in the securities and investment banking industry since April 2021. Aurora Capital Corp., a corporation wholly owned by Mr. Margolis, is a significant equity owner and managing member of Aurora Capital LLC. Mr. Margolis and Dr. Lippa founded and jointly managed, since 2004, Atypical BioCapital Management LLC and Atypical BioVentures Fund LLC, a life sciences fund management company and venture fund, respectively. Both entities are currently inactive.